SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-21-015629
Filing Date
2021-11-12
Accepted
2021-11-12 07:01:42
Documents
49
Period of Report
2021-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q mist-20210930x10q.htm   iXBRL 10-Q 1393721
2 EX-31.1 mist-20210930xex31d1.htm EX-31.1 12317
3 EX-31.2 mist-20210930xex31d2.htm EX-31.2 12468
4 EX-32.1 mist-20210930xex32d1.htm EX-32.1 9441
  Complete submission text file 0001558370-21-015629.txt   4913128

Data Files

Seq Description Document Type Size
5 EX-101.SCH mist-20210930.xsd EX-101.SCH 28426
6 EX-101.CAL mist-20210930_cal.xml EX-101.CAL 27908
7 EX-101.DEF mist-20210930_def.xml EX-101.DEF 112189
8 EX-101.LAB mist-20210930_lab.xml EX-101.LAB 271695
9 EX-101.PRE mist-20210930_pre.xml EX-101.PRE 201975
10 EXTRACTED XBRL INSTANCE DOCUMENT mist-20210930x10q_htm.xml XML 910100
Mailing Address 1111 BOUL. DR.-FREDERIK-PHILIPS, STE 420 MONTREAL A8 H4M 2X6
Business Address 1111 BOUL. DR.-FREDERIK-PHILIPS, STE 420 MONTREAL A8 H4M 2X6 (514) 336-0444
Milestone Pharmaceuticals Inc. (Filer) CIK: 0001408443 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A8 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38899 | Film No.: 211399462
SIC: 2834 Pharmaceutical Preparations